SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

AVXL RSS Feed
Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, blanka, TheHound, 123tom, TomP1, Rubyred77
Search This Board:
Last Post: 1/24/2017 10:12:56 AM - Followers: 667 - Board type: Free - Posts Today: 68

Anavex Life Sciences Corp (AVXL)



Company website:  http://www.anavex.com/
 
 Nasdaq 
 
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA
1-844-689-3939

 
CIK:  0001314052
 
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s, CNS diseases and various types of cancer, which have significant unmet medical needs.
 
ANAVEX 2-73, the Company’s orally available drug candidate developed to treat Alzheimer’s through potential disease modification, has undergone an initial Phase 1 human clinical trial and was well tolerated in doses up to 55mg.  Results from pre-clinical studies indicate that ANAVEX 2-73 demonstrates anti-amnesic and neuroprotective properties.
 
A highly encouraging synergistic effect has also been observed between ANAVEX 2-73 and donepezil (Aricept®).  The combined therapeutics, referred to as “ANAVEX PLUS,” produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually.
 
ANAVEX PLUS is believed to be a compelling commercial opportunity.  The clinical trial risk is lower because donepezil (Aricept®) is already on the market, with global sales of $4-billion annually.  Donepezil (Aricept®) is now generic and a patent application has been filed for ANAVEX PLUS which, if granted, would provide protection until 2033.
 
Management:   http://www.anavex.com/about-us/leadership/
 
Pipeline:  http://www.anavex.com/pipeline/

Patent Info: 
http://www.anavex.com/?s=patents

Clinical Trials:  https://clinicaltrials.gov/ct2/results?term=Anavex+Life+Sciences&Search=Search
 
Recent News:  http://finance.yahoo.com/q?s=avxl&ql=1
Company News Releases:  http://www.anavex.com/2015/?post_type=news
 
Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=anavex&owner=exclude&action=getcompany
 
Share Structure:  See SEC filings
 
Investor Relations:  [email protected]

Marketing Details:  http://convention.bio.org/Printables/Anavex%20Life%20Sciences%20Corp..html

 



All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
AVXL News: Anavex Life Sciences to Present at Noble Capital Markets’ Thirteenth Annual Investor Conference 01/23/2017 08:00:00 AM
AVXL News: Anavex Life Sciences Receives Grant From Rettsyndrome.org to Commence U.S. Phase 2 Trial in 2017 01/19/2017 07:00:00 AM
AVXL News: Anavex Life Sciences Obtains Permanent Dismissal of All Claims in Securities Lawsuit 01/03/2017 07:00:00 AM
AVXL News: Annual Report (10-k) 12/14/2016 04:09:24 PM
AVXL News: Traders News Issues New Reports and Features a New OTCQB Company Profile 12/13/2016 09:25:00 AM
PostSubject
#86140  Sticky Note Many Zeros falconer66a 12/30/16 06:23:25 PM
#86075  Sticky Note CLERK'S JUDGMENT: It is, ORDERED, ADJUDGED AND DECREED: neiu 12/30/16 02:05:41 AM
#84929  Sticky Note falcobner66a DM is an uncompetitive N-methyl-d-aspartate (NMDA) gluta georgejjl 12/20/16 12:10:56 PM
#88632   Your sense makes no sense brichnyc 01/24/17 10:12:55 AM
#88631   You are incorrect, but the Administrators evidently didn't LakeshoreLeo1953 01/24/17 10:09:46 AM
#88630   The company currently has 1 US patent and gburgin 01/24/17 10:05:30 AM
#88629   All well and good Xena, but those who LakeshoreLeo1953 01/24/17 09:58:10 AM
#88628   Anavex has a drug PLATFORM - many patents XenaLives 01/24/17 09:48:33 AM
#88627   Those questions seem ill informed as each is LakeshoreLeo1953 01/24/17 09:46:33 AM
#88625   "no one has offered a satisfactory answer on gburgin 01/24/17 09:41:43 AM
#88624   Other than US Patent granted for "A3-71" the LakeshoreLeo1953 01/24/17 09:41:10 AM
#88623   I go with the companies SEC form which TomP1 01/24/17 09:41:07 AM
#88622   Thank you for backing up my claim. Ziggydmz1 01/24/17 09:40:28 AM
#88621  Restored Alternative fact? TomP1 01/24/17 09:38:17 AM
#88620   2-73 has adequate and usual IP protection. XenaLives 01/24/17 09:37:58 AM
#88619  Restored Lets focus on getting a patent before discussing TomP1 01/24/17 09:36:35 AM
#88618   It clearly says patent pending. So nothing dubious TomP1 01/24/17 09:34:48 AM
#88617   The Alzheimer protection is the key to future partnership. TomP1 01/24/17 09:33:37 AM
#88616   I've seen the Greek patent and it had gburgin 01/24/17 09:30:32 AM
#88615   I get the sense that a short attack powerwalker 01/24/17 09:28:17 AM
#88613  Restored It has to do with over confidence stating Amatuer17 01/24/17 09:23:37 AM
#88611   There is a Greek patent for the original Ziggydmz1 01/24/17 09:20:21 AM
#88610   They had a broad patent from the inventor XenaLives 01/24/17 09:16:50 AM
#88609   But WHEN the expiration of a Patent occurs LakeshoreLeo1953 01/24/17 09:16:45 AM
#88608   YES - XenaLives 01/24/17 09:15:14 AM
#88607   No basis in fact: XenaLives 01/24/17 09:14:39 AM
#88606   Very True. LakeshoreLeo1953 01/24/17 09:14:09 AM
#88605   YOU HAVE TO FIRST HAVE A PATENT BEFORE camk 01/24/17 09:13:48 AM
#88604   Zena, then is it your opinion that lack gburgin 01/24/17 09:13:40 AM
#88602   THIS IS FOR CANCER ONLY !!!!!!!!!! camk 01/24/17 09:12:27 AM
#88601   Link has nothing to do with limited trials XenaLives 01/24/17 09:11:56 AM
#88600   Yes...not the only avenue...it is just the most Ziggydmz1 01/24/17 09:11:20 AM
#88599   IP issues and Patent issues are NOT the same. XenaLives 01/24/17 09:10:56 AM
#88598   Thank...I have been trying to get that point Ziggydmz1 01/24/17 09:07:59 AM
#88597   And BP is evidently dealing with it in LakeshoreLeo1953 01/24/17 09:06:31 AM
#88596  Restored I posted this several times - patent expiration XenaLives 01/24/17 08:41:52 AM
#88595   It seems pretty clear to me. This copied k9uwa 01/24/17 08:41:10 AM
#88594  Restored Very humbling story on drug development. Specially for Amatuer17 01/24/17 08:33:03 AM
#88593   what happens when A2-73 is declared RAT? McMagyar 01/24/17 08:30:56 AM
#88592  Restored Just saying: there's more than meets the board's kld2 01/24/17 08:19:04 AM
#88591   Patents are NOT the only form of IP XenaLives 01/24/17 08:12:48 AM
#88590   I would not buy somebody else's house without kld2 01/24/17 08:11:14 AM
#88589   10Ks are full of boilerplate disclaimers and warnings XenaLives 01/24/17 08:11:00 AM
#88588   Correct. frrol 01/24/17 08:10:39 AM
#88587   "So for once and for all: 2-73 either gburgin 01/24/17 08:06:05 AM
#88586   Please elaborate your reasoning. TomP1 01/24/17 07:59:22 AM
#88585   "I stand corrected ..this patent was issued 9,180,106 " gburgin 01/24/17 07:58:30 AM
#88584   That's what contingencies are for. Jonjones325 01/24/17 07:58:02 AM
#88583  Restored "So how can Missling say that IP is gburgin 01/24/17 07:51:06 AM
#88582   And patent issuance, unequivocally, is the key to TomP1 01/24/17 07:42:56 AM
#88581   I distinctly remember Missling saying in an interview kld2 01/24/17 07:33:00 AM
#88580   I stand corrected ..this patent was issued 9,180,106 Mikesc 01/24/17 07:29:25 AM
#88579   To make life easy: http://www.anavex.com/?news=anavex-announces-fiscal-2015-yea TomP1 01/24/17 07:22:36 AM
PostSubject